Ascierto PA, McArthur GA, Dréno B, Atkinson V, Liszkay G, Di Giacomo AM, et al. Cobimetinib combined with vemurafenib in advanced BRAF(V600)-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial. Lancet Oncol 2016 Sep;17(9):1248-60 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/27480103.
Compare quality appraisals for each clinical question
- Does systemic drug therapy improve progression-free, overall survival in unresectable stage III and stage IV melanoma?